Vitamin D, Skin, and Bone Research Laboratory, Section Endocrinology, Diabetes, Nutrition and Weight Management, Department of Medicine, Boston University School of Medicine, 85 E Newton St, M-1013, Boston, MA 01228, USA.
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Nutrients. 2020 Jul 15;12(7):2097. doi: 10.3390/nu12072097.
Vitamin D is responsible for regulation of calcium and phosphate metabolism and maintaining a healthy mineralized skeleton. It is also known as an immunomodulatory hormone. Experimental studies have shown that 1,25-dihydroxyvitamin D, the active form of vitamin D, exerts immunologic activities on multiple components of the innate and adaptive immune system as well as endothelial membrane stability. Association between low levels of serum 25-hydroxyvitamin D and increased risk of developing several immune-related diseases and disorders, including psoriasis, type 1 diabetes, multiple sclerosis, rheumatoid arthritis, tuberculosis, sepsis, respiratory infection, and COVID-19, has been observed. Accordingly, a number of clinical trials aiming to determine the efficacy of administration of vitamin D and its metabolites for treatment of these diseases have been conducted with variable outcomes. Interestingly, recent evidence suggests that some individuals might benefit from vitamin D more or less than others as high inter-individual difference in broad gene expression in human peripheral blood mononuclear cells in response to vitamin D supplementation has been observed. Although it is still debatable what level of serum 25-hydroxyvitamin D is optimal, it is advisable to increase vitamin D intake and have sensible sunlight exposure to maintain serum 25-hydroxyvitamin D at least 30 ng/mL (75 nmol/L), and preferably at 40-60 ng/mL (100-150 nmol/L) to achieve the optimal overall health benefits of vitamin D.
维生素 D 负责调节钙和磷代谢,维持健康的矿化骨骼。它也被称为免疫调节激素。实验研究表明,维生素 D 的活性形式 1,25-二羟维生素 D 对先天和适应性免疫系统的多个成分以及内皮膜稳定性具有免疫活性。观察到血清 25-羟维生素 D 水平低与多种与免疫相关的疾病和病症(包括银屑病、1 型糖尿病、多发性硬化症、类风湿性关节炎、结核病、脓毒症、呼吸道感染和 COVID-19)的发病风险增加有关。因此,已经进行了许多临床试验,旨在确定维生素 D 及其代谢物用于治疗这些疾病的疗效,但结果不一。有趣的是,最近的证据表明,由于人类外周血单核细胞对维生素 D 补充的广泛基因表达存在个体间差异很大,因此一些人可能比其他人更受益于维生素 D 或受益较少。尽管血清 25-羟维生素 D 的最佳水平仍存在争议,但建议增加维生素 D 的摄入量并进行适度的阳光照射,以使血清 25-羟维生素 D 至少达到 30ng/ml(75nmol/L),最好达到 40-60ng/ml(100-150nmol/L),以实现维生素 D 的最佳整体健康益处。